Amneal Pharmaceuticals (NASDAQ:AMRX) Shares Gap Up to $2.19

Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRXGet Rating) gapped up prior to trading on Friday . The stock had previously closed at $2.19, but opened at $2.29. Amneal Pharmaceuticals shares last traded at $2.28, with a volume of 3,290 shares traded.

Analyst Ratings Changes

Separately, StockNews.com lowered shares of Amneal Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Tuesday, November 1st.

Amneal Pharmaceuticals Trading Up 2.3 %

The firm has a market capitalization of $680.04 million, a P/E ratio of -2.57, a price-to-earnings-growth ratio of 0.15 and a beta of 1.26. The company has a current ratio of 1.74, a quick ratio of 1.07 and a debt-to-equity ratio of 13.62.

Amneal Pharmaceuticals Company Profile

(Get Rating)

Amneal Pharmaceuticals, Inc, together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories.

See Also

Receive News & Ratings for Amneal Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amneal Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.